Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases-Reference-Cited by-同舟云学术

Discovery of the First Subnanomolar PPARα/δ Dual Agonist for the Treatment of Cholestatic Liver Diseases

Published:2023-05-27 Issue:11 Volume:66 Page:7331-7354
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Feng Zhiqi¹,Xiang Jiehao¹,Sun Gang¹^ORCID,Liu Hui¹,Wang Yanyan¹,Liu Xin¹,Feng Jin¹,Xu Qinglong¹^ORCID,Wen Xiaoan¹,Yuan Haoliang¹^ORCID,Sun Hongbin¹²^ORCID,Dai Liang¹^ORCID

Affiliation:

1. Jiangsu Key Laboratory of Drug Discovery for Metabolic Disease, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China

2. Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401135, China

Funder

Natural Science Foundation of Jiangsu Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c02123

Reference43 articles.

1. The ascending pathophysiology of cholestatic liver disease